Business Context and Reporting Period
Company: Ecolab Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 9, 2007
Event: Completion of the acquisition of Microtek Medical Holdings, Inc. ("Microtek").
Key Financial Metrics
Acquisition Price: $6.30 per share in cash for all outstanding shares of Microtek.
Funding Source: Issuance and sale of commercial paper under Ecolab's U.S. commercial paper program.
Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, total debt, or liquidity ratios for the reporting period.
Material Changes
- Corporate Structure: Microtek is now a wholly owned subsidiary of Ecolab following a merger with Magic Acquisition Inc. (Merger Sub).
- Transaction Status: The acquisition was consummated pursuant to the Merger Agreement dated August 7, 2007.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the successful closing of the transaction and references a news release (Exhibit 99) for further details.
Risks and Contingencies: The filing text does not explicitly detail new risks, contingencies, or unusual items beyond the execution of the merger.
Guidance: No updated financial guidance or outlook is provided in this specific filing text.
Investor Verification Checklist
- Verify the total aggregate purchase price paid for Microtek (calculated as $6.30 multiplied by the total number of outstanding shares).
- Review the attached News Release (Exhibit 99) for strategic rationale and expected synergies.
- Confirm the impact of the commercial paper issuance on Ecolab's short-term debt obligations and liquidity position.
- Check subsequent filings for the pro forma financial impact of the acquisition.